Anti-Inflammatory Injection (Unknown)

Verify with FDA CVM →

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
12
Total Reports
1
Deaths Reported
830.0%
Death Rate

Active Ingredients

Anti-Inflammatory Injection (Unknown)

Administration Routes

UnknownSubcutaneousParenteral

Species Affected

Dog 12

Most Affected Breeds

Shih Tzu 3
Spaniel - Cocker American 1
Terrier - Yorkshire 1
Chow Chow 1
Spaniel - Springer English 1
Retriever - Labrador 1
Poodle - Miniature 1
Crossbred Canine/dog 1
Saint Bernard Dog 1
Chihuahua 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 4
Diarrhoea 3
Seizure NOS 3
Agitation 3
Cough 2
Behavioural disorder NOS 2
Nystagmus 2
Staggering 2
Vestibular disorder NOS 2
High blood pressure 2
Elevated lactate 2
Falling 2

Outcome Breakdown

Recovered/Normal
5 (41.7%)
Recovered with Sequela
3 (25.0%)
Ongoing
2 (16.7%)
Died
1 (8.3%)
Outcome Unknown
1 (8.3%)

Data Summary

Metric Value
Total adverse event reports 12
Reports involving death 1
Case-fatality rate (reported events) 830.0%
Distinct species in reports 1
Distinct breeds in reports 10
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Anti-Inflammatory Injection (Unknown) Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 12 adverse event reports referencing Anti-Inflammatory Injection (Unknown), including 1 reports in which the animal died — a 830.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Anti-Inflammatory Injection (Unknown). Reported administration routes include Unknown, Subcutaneous, Parenteral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Anti-Inflammatory Injection (Unknown) reports are Dog (12 reports), with Dog accounting for the largest share. Within those species, Shih Tzu (3), Spaniel - Cocker American (1), Terrier - Yorkshire (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Anti-Inflammatory Injection (Unknown) are Lethargy (see also Central nervous system depression in 'Neurological') (4), Diarrhoea (3), Seizure NOS (3), Agitation (3). Of the 12 reports with a coded outcome, Recovered/Normal is the leading category at 41.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Anti-Inflammatory Injection (Unknown).

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial